Mandate

Vinge advised Orexo on bond issue

November 02, 2017

Orexo AB (publ) has issued a four-year senior unsecured bond loan of SEK 325 million, within a framework amount of SEK 500 million.

The bonds are intended to be listed on Nasdaq Stockholm.
 
Vinge acted as legal adviser to Orexo. The Vinge team included partners Erik Sjöman and Henrik Ossborn, and associates Christian Lindhé, Fredrik Christiansson and Astrid Karlsson.  
 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025